Notes from Joe Update on the Alliance’s Work on an Intranasal DDAVP by Joe Pugliese Dear Community: In July 2020, Ferring Pharmaceuticals, announced a voluntary recall of all batches of Read the full article…
Notes from Joe Protecting Program Income by Joe Pugliese This month, we’re trying something new with the Newsletter. Each month, we provide you with a series of articles on different Read the full article…
Notes from Joe Imagine That by Joe Pugliese There are only a couple of good things we can say about the last 12 months, probably the most important is we Read the full article…
Notes from Joe Interesting by Joe Pugliese It’s hard to believe that we’re already half-way through February! The dust is starting to settle in DC. There are 62 new Representatives Read the full article…
Notes from Joe Keep Going by Joe Pugliese There is an old saying, when going through hell, keep going. The optimist would say that is because hell is finite. The Read the full article…
Before we dive deeper into all we’ve been through and accomplished this year, I want to give a very exciting breaking news highlight for the community.
The big news has to be the recent announcements by Pfizer, Moderna and Astra Zeneca about their COVID-19 vaccine clinical trials.
All of the recent news, including the hearings about our potential new Supreme Court Justice, highlight that people are worried, concerned, and fixated on the cost and access to health care and of course, since it’s an election year, people want to know who to blame. The short answer is all of us, but then it gets more complicated.
As of this writing, we are in something like day 190 of the hostage crisis.
Wow, after waiting 25 plus years for a gene therapy product for the hemophilia community, it never occurred to me that Biomarin’s product would be rejected by the FDA last week with a call for additional data on the durability of their product.
